These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 1974245)
1. Beta-adrenergic therapy for glaucoma. Polansky JR Int Ophthalmol Clin; 1990; 30(3):219-29. PubMed ID: 1974245 [No Abstract] [Full Text] [Related]
2. Adrenergic drug effects on cyclic AMP in cultured human trabecular meshwork cells. Friedman Z; Bloom E; Polansky JR Ophthalmic Res; 1999; 31(1):53-8. PubMed ID: 9831823 [TBL] [Abstract][Full Text] [Related]
3. Adenylyl cyclase activity mediated by beta-adrenoceptors in immortalized human trabecular meshwork and non-pigmented ciliary epithelial cells. Crider JY; Sharif NA J Ocul Pharmacol Ther; 2002 Jun; 18(3):221-30. PubMed ID: 12099543 [TBL] [Abstract][Full Text] [Related]
4. Beta-adrenergic blocker therapy and the trabecular meshwork. Gottanka J; Johnson DH; Martus P; Lütjen-Drecoll E Graefes Arch Clin Exp Ophthalmol; 2001 Feb; 239(2):138-44. PubMed ID: 11372544 [TBL] [Abstract][Full Text] [Related]
5. Treatment of glaucoma by prostaglandin agonists and beta-blockers in combination directly reduces pro-fibrotic gene expression in trabecular meshwork. Tejwani S; Machiraju P; Nair AP; Ghosh A; Das RK; Ghosh A; Sethu S J Cell Mol Med; 2020 May; 24(9):5195-5204. PubMed ID: 32267082 [TBL] [Abstract][Full Text] [Related]
6. [The effects of epinephrine and adrenergic antagonists on adenosine 3', 5'-monophosphate level of bovine trabecular cells in vitro]. Lu Y; Li M; Shen Y Zhonghua Yan Ke Za Zhi; 1998 Mar; 34(2):124-6. PubMed ID: 11877172 [TBL] [Abstract][Full Text] [Related]
7. [The effects of adrenergic antagonists on epinephrine determined by the assay of adenosine 3',5'-monophosphate in bovine trabecular cells in vitro]. Lu Y; Li M; Shen Y Zhonghua Yan Ke Za Zhi; 1997 Sep; 33(5):373-5. PubMed ID: 10451986 [TBL] [Abstract][Full Text] [Related]
8. Epinephrine effects on major cell types of the aqueous outflow pathway: in vitro studies/clinical implications. Alvarado JA; Franse-Carman L; McHolm G; Murphy C Trans Am Ophthalmol Soc; 1990; 88():267-82; discussion 283-8. PubMed ID: 1982749 [TBL] [Abstract][Full Text] [Related]
9. Observations on the pharmacology of glaucoma. Leopold IH; Duzman E Annu Rev Pharmacol Toxicol; 1986; 26():401-26. PubMed ID: 2872854 [No Abstract] [Full Text] [Related]
10. Drugs and the trabecular meshwork. Kaufman PL Invest Ophthalmol Vis Sci; 1977 Jun; 16(6):475-7. PubMed ID: 16830 [No Abstract] [Full Text] [Related]
11. [Beta-stimulants and beta-blockers. Their role in the medical treatment of open-angle glaucoma]. Weekers R; Collignon-Brach J J Fr Ophtalmol; 1981; 4(2):149-55. PubMed ID: 6113257 [No Abstract] [Full Text] [Related]
17. Topical adrenergic potentiators in primary open-angle glaucoma. Kitazawa Y Am J Ophthalmol; 1972 Oct; 74(4):588-93. PubMed ID: 4403873 [No Abstract] [Full Text] [Related]
18. Epinephrine increases facility of outflow and cyclic AMP content in the human eye in vitro. Erickson-Lamy KA; Nathanson JA Invest Ophthalmol Vis Sci; 1992 Aug; 33(9):2672-8. PubMed ID: 1353486 [TBL] [Abstract][Full Text] [Related]
19. Effect of beta-adrenergic drugs on adenosine 3', 5'-monophosphate in rabbit vagus nerve. Roch P; Salamin A J Neurochem; 1977 May; 28(5):947-50. PubMed ID: 16990 [No Abstract] [Full Text] [Related]